132 related articles for article (PubMed ID: 38456842)
1. Expanding FTMap for Fragment-Based Identification of Pharmacophore Regions in Ligand Binding Sites.
Khan O; Jones G; Lazou M; Joseph-McCarthy D; Kozakov D; Beglov D; Vajda S
J Chem Inf Model; 2024 Mar; 64(6):2084-2100. PubMed ID: 38456842
[TBL] [Abstract][Full Text] [Related]
2. The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins.
Kozakov D; Grove LE; Hall DR; Bohnuud T; Mottarella SE; Luo L; Xia B; Beglov D; Vajda S
Nat Protoc; 2015 May; 10(5):733-55. PubMed ID: 25855957
[TBL] [Abstract][Full Text] [Related]
3. FTMAP: extended protein mapping with user-selected probe molecules.
Ngan CH; Bohnuud T; Mottarella SE; Beglov D; Villar EA; Hall DR; Kozakov D; Vajda S
Nucleic Acids Res; 2012 Jul; 40(Web Server issue):W271-5. PubMed ID: 22589414
[TBL] [Abstract][Full Text] [Related]
4. Hot spot analysis for driving the development of hits into leads in fragment-based drug discovery.
Hall DR; Ngan CH; Zerbe BS; Kozakov D; Vajda S
J Chem Inf Model; 2012 Jan; 52(1):199-209. PubMed ID: 22145575
[TBL] [Abstract][Full Text] [Related]
5. Fragment-based identification of druggable 'hot spots' of proteins using Fourier domain correlation techniques.
Brenke R; Kozakov D; Chuang GY; Beglov D; Hall D; Landon MR; Mattos C; Vajda S
Bioinformatics; 2009 Mar; 25(5):621-7. PubMed ID: 19176554
[TBL] [Abstract][Full Text] [Related]
6. Robust identification of binding hot spots using continuum electrostatics: application to hen egg-white lysozyme.
Hall DH; Grove LE; Yueh C; Ngan CH; Kozakov D; Vajda S
J Am Chem Soc; 2011 Dec; 133(51):20668-71. PubMed ID: 22092261
[TBL] [Abstract][Full Text] [Related]
7. FTFlex: accounting for binding site flexibility to improve fragment-based identification of druggable hot spots.
Grove LE; Hall DR; Beglov D; Vajda S; Kozakov D
Bioinformatics; 2013 May; 29(9):1218-9. PubMed ID: 23476022
[TBL] [Abstract][Full Text] [Related]
8. Benchmark Sets for Binding Hot Spot Identification in Fragment-Based Ligand Discovery.
Wakefield AE; Yueh C; Beglov D; Castilho MS; Kozakov D; Keserű GM; Whitty A; Vajda S
J Chem Inf Model; 2020 Dec; 60(12):6612-6623. PubMed ID: 33291870
[TBL] [Abstract][Full Text] [Related]
9. FTMove: A Web Server for Detection and Analysis of Cryptic and Allosteric Binding Sites by Mapping Multiple Protein Structures.
Egbert M; Jones G; Collins MR; Kozakov D; Vajda S
J Mol Biol; 2022 Jun; 434(11):167587. PubMed ID: 35662465
[TBL] [Abstract][Full Text] [Related]
10. Druggable hot spots in trypanothione reductase: novel insights and opportunities for drug discovery revealed by DRUGpy.
Teixeira O; Lacerda P; Froes TQ; Nonato MC; Castilho MS
J Comput Aided Mol Des; 2021 Aug; 35(8):871-882. PubMed ID: 34181199
[TBL] [Abstract][Full Text] [Related]
11. Detection of ligand binding hot spots on protein surfaces via fragment-based methods: application to DJ-1 and glucocerebrosidase.
Landon MR; Lieberman RL; Hoang QQ; Ju S; Caaveiro JM; Orwig SD; Kozakov D; Brenke R; Chuang GY; Beglov D; Vajda S; Petsko GA; Ringe D
J Comput Aided Mol Des; 2009 Aug; 23(8):491-500. PubMed ID: 19521672
[TBL] [Abstract][Full Text] [Related]
12. Analysis of protein binding sites by computational solvent mapping.
Hall DR; Kozakov D; Vajda S
Methods Mol Biol; 2012; 819():13-27. PubMed ID: 22183527
[TBL] [Abstract][Full Text] [Related]
13. Mapping the binding sites of challenging drug targets.
Wakefield AE; Kozakov D; Vajda S
Curr Opin Struct Biol; 2022 Aug; 75():102396. PubMed ID: 35636004
[TBL] [Abstract][Full Text] [Related]
14. Conservation of Allosteric Ligand Binding Sites in G-Protein Coupled Receptors.
Wakefield AE; Bajusz D; Kozakov D; Keserű GM; Vajda S
J Chem Inf Model; 2022 Oct; 62(20):4937-4954. PubMed ID: 36195573
[TBL] [Abstract][Full Text] [Related]
15. Interaction Energetics and Druggability of the Protein-Protein Interaction between Kelch-like ECH-Associated Protein 1 (KEAP1) and Nuclear Factor Erythroid 2 Like 2 (Nrf2).
Zhong M; Lynch A; Muellers SN; Jehle S; Luo L; Hall DR; Iwase R; Carolan JP; Egbert M; Wakefield A; Streu K; Harvey CM; Ortet PC; Kozakov D; Vajda S; Allen KN; Whitty A
Biochemistry; 2020 Feb; 59(4):563-581. PubMed ID: 31851823
[TBL] [Abstract][Full Text] [Related]
16. Mapping the druggable allosteric space of G-protein coupled receptors: a fragment-based molecular dynamics approach.
Ivetac A; McCammon JA
Chem Biol Drug Des; 2010 Sep; 76(3):201-17. PubMed ID: 20626410
[TBL] [Abstract][Full Text] [Related]
17. Flexi-pharma: a molecule-ranking strategy for virtual screening using pharmacophores from ligand-free conformational ensembles.
Lans I; Palacio-Rodríguez K; Cavasotto CN; Cossio P
J Comput Aided Mol Des; 2020 Oct; 34(10):1063-1077. PubMed ID: 32656619
[TBL] [Abstract][Full Text] [Related]
18. Exploring the potential of protein-based pharmacophore models in ligand pose prediction and ranking.
Hu B; Lill MA
J Chem Inf Model; 2013 May; 53(5):1179-90. PubMed ID: 23621564
[TBL] [Abstract][Full Text] [Related]
19. Targeting the NF-κB/IκBα complex via fragment-based E-Pharmacophore virtual screening and binary QSAR models.
Kanan T; Kanan D; Erol I; Yazdi S; Stein M; Durdagi S
J Mol Graph Model; 2019 Jan; 86():264-277. PubMed ID: 30415122
[TBL] [Abstract][Full Text] [Related]
20. PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach.
Liu X; Ouyang S; Yu B; Liu Y; Huang K; Gong J; Zheng S; Li Z; Li H; Jiang H
Nucleic Acids Res; 2010 Jul; 38(Web Server issue):W609-14. PubMed ID: 20430828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
